US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...

Health Secretary Robert Kennedy Jr. has replaced all members of the CDC's vaccine advisory panel with a group that includes ...

Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 2:00 PM ETCompany ParticipantsJames Patrick Kelly ...

The World Health Organization is keeping an eye on a new COVID-19 variant called NB.1.8.1, or “Nimbus,” that has spread across Europe, the Americas and the Western Pacific.   Nimbus is ...

U.S. Health Secretary Robert Kennedy Jr. on Wednesday named new members to serve on a key panel of vaccine advisers after ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Novavax (NasdaqGS:NVAX) recently reported initial results from its Phase 3 trial for its COVID-19-Influenza Combination and seasonal influenza vaccines, which showed immune responses comparable to ...

The XEC COVID variant, a recombinant Omicron sublineage, is now dominant across the world, spreading rapidly but not causing ...

Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 ...

The FDA is adopting a new regulatory framework that will change the criteria for approval of COVID-19 vaccines.

Novavax, Inc. (NVAX) on Wednesday said that its COVID-19-Influenza combination and stand-alone Influenza vaccine candidates ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...